GSZPX
Price
$24.05
Change
+$0.60 (+2.56%)
Updated
Apr 24 closing price
Net Assets
115.83M
VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
Ad is loading...

GSZPX vs VEXRX

Header iconGSZPX vs VEXRX Comparison
Open Charts GSZPX vs VEXRXBanner chart's image
Goldman Sachs Small Cap Gr Insghts P
Price$24.05
Change+$0.60 (+2.56%)
VolumeN/A
Net Assets115.83M
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
GSZPX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSZPX vs. VEXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSZPX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. GSZPX (116M). GSZPX pays higher dividends than VEXRX: GSZPX (0.90) vs VEXRX (0.56). GSZPX was incepted earlier than VEXRX: GSZPX (7 years) vs VEXRX (23 years). GSZPX (1.06) is less costly to investors than VEXRX (0.34). GSZPX is a more actively managed with annual turnover of: 166.00 vs. VEXRX (35.00). GSZPX has a lower initial minimum investment than VEXRX: GSZPX (0) vs VEXRX (50000). GSZPX annual gain was more profitable for investors over the last year : 1.85 vs. VEXRX (-11.24). VEXRX return over 5 years is better than : 17.63 vs. GSZPX (-30.58).
GSZPXVEXRXGSZPX / VEXRX
Total Expense Ratio0.840.34247%
Annual Report Gross Expense Ratio1.060.34312%
Fund Existence7 years23 years-
Gain YTD-14.541-13.374109%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets116M19.8B1%
Annual Yield % from dividends0.900.56161%
Returns for 1 year1.85-11.24-16%
Returns for 3 years14.68-8.96-164%
Returns for 5 years-30.5817.63-173%
Returns for 10 yearsN/A0.85-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI80.891.79
+2.26%
SPDR® S&P Biotech ETF
FEP42.410.74
+1.78%
First Trust Europe AlphaDEX® ETF
SBIO28.510.49
+1.75%
ALPS Medical Breakthroughs ETF
BCDF28.980.44
+1.54%
Horizon Kinetics Blockchain Dev ETF
CHI9.920.14
+1.43%
Calamos Convertible Opportunities and Income Fund